Mdxhealth Sa (MXDHF) 4.2500 $MXDHF MDxHealth Appoints

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mdxhealth Sa (MXDHF) 4.2500 $MXDHF

MDxHealth Appoints Walter Narajowski as Independent Director
GlobeNewswire - Mon Oct 05, 1:36AM CDT
MDxHealth SA (Euronext: MDXH.BR), today announces that it has strengthened its Board of Directors with the appointment of Mr. Walter Narajowski, a medical diagnostics business leader with over 25 years of industry experience.
ROKA: 1.94 (unch), DGX: 63.26 (+0.26)

MDxHealth(R): Completion of the acquisition of NovioGendix - New share capital amount and new number of shares
GlobeNewswire - Fri Sep 18, 10:32AM CDT
MDxHealth SA (Euronext Brussels: MDXH) (the "Company" announced today that it succesfully completed the acquisition of all of the shares in NovioGendix Holding B.V. ("NovioGendix" . The acquisition of NovioGendix was announced on September 15, 2015 and the completion of the acquisition took place on September 18, 2015.

MDxHealth's ConfirmMDx Covered by Tufts Health Plan
GlobeNewswire - Thu Sep 17, 12:05AM CDT
MDxHealth SA (Euronext: MDXH.BR) announced that it has signed an agreement with Tufts Health Plan for their government and commercial programs/products. The agreement provides access to ConfirmMDx for Prostate Cancer testing for Tufts Health Plan's 1 million members.

MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering
GlobeNewswire - Tue Sep 15, 12:05AM CDT
-- The acquisition gives MDxHealth access to a validated, non-invasive liquid biopsy test for prostate cancer in the US and EU

MDxHealth Reports New ConfirmMDx Risk Score Data at 11th World Congress on Urological Research
GlobeNewswire - Thu Sep 10, 12:04AM CDT
MDxHealth SA (Euronext: MDXH), today announced data demonstrating that a newly developed algorithm, based on ConfirmMDx test scores (ConfirmMDx Risk Score), stratifies men with DNA methylation positive prostate biopsies for risk of low and high-grade prostate cancer (PCa). The data will be presented at the 11th World Congress on Urological Research in Nijmegen, The Netherlands, 9-11 September 2015 (http://esur-sbur.uroweb.org).

MDxHealth Reports First Half 2015 Results
GlobeNewswire - Thu Aug 20, 12:05AM CDT
-- Revenues up 64% to $7.9 million

MDxHealth Announces Positive Top-Line Data for its Liquid Biopsy Test for Bladder Cancer
GlobeNewswire - Tue Aug 18, 12:06AM CDT
Signs worldwide exclusive agreement with Erasmus MC for bladder cancer DNA methylation markers

MDxHealth Appoints Philip J. Ginsburg M.D. as Chief Medical Officer
GlobeNewswire - Tue Jul 14, 12:06AM CDT
MDxHealth SA (Euronext: MDXH), announced today, the appointment of Philip J. Ginsburg, MD, as Chief Medical Officer (CMO). Dr. Ginsburg joins the company with over 20 years of commercial medical laboratory and urology experience. In this new role, Dr. Ginsburg will have overall responsibility for clinical strategy, including scientific and clinical affairs.

MDxHealth's ConfirmMDx(r) Predicts Prostate Cancer Aggressiveness
GlobeNewswire - Mon May 18, 1:05AM CDT
Epigenetic Health Index Helps Urologists with Prognostic Recommendations

MDxHealth Provides First Quarter 2015 Business Update
GlobeNewswire - Tue May 05, 1:13AM CDT
ConfirmMDx Test Revenue Increases 177% over First Quarter 2014

MDxHealth: Exploiting A Valuation Anomaly Between Exact Sciences And Their European Licensor
VMK Investment Research - at Seeking Alpha - Wed Apr 29, 4:31PM CDT

EXAS: 8.51 (+0.71)

MDxHealth Named Winner of Corporate LiveWire Innovation & Excellence 2015 Award
GlobeNewswire - Fri Apr 24, 2:18AM CDT
MDxHealth SA (Euronext: MDXH.BR) announced today that it has been named as one of the winners of the Corporate LiveWire Innovation & Excellence Awards. The awards are in recognition of innovation and excellence that recipient companies, teams and individuals have shown amid ongoing global economic uncertainty.

MDxHealth Completes Enrollment of Second ConfirmMDx Clinical Utility Study
GlobeNewswire - Mon Apr 20, 1:03AM CDT
MDxHealth SA (Euronext: MDXH.BR) today announced that it has completed patient enrollment into its prospective, randomized PASCUAL clinical utility study with ConfirmMDx for Prostate Cancer. The study, which will evaluate the impact of the ConfirmMDx test results on physician decisions for repeat biopsy, enrolled 600 patients from 17 leading urology practices across the U.S.

MyCartis Announces Appointment of Dr. Jan Groen to Its Board of Directors
PR Newswire Europe - Thu Apr 09, 1:01AM CDT
GHENT, Belgium and LAUSANNE, Switzerland, April 9, 2015 /PRNewswire/ --

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer
GlobeNewswire - Mon Mar 02, 1:08AM CST
MDxHealth SA (Euronext: MDXH.BR), today announced that data demonstrating the prognostic value of its ConfirmMDx for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015 in Rosen Shingle Creek, Orlando, Florida, USA (February 26-28, 2015). The data support the ability to predict the presence of clinically significant cancer in biopsy-negative patients based on the DNA hypermethylation of the biomarkers in the ConfirmMDx test.

A European Biotech Stock Basket For 2015
Logribel Biostocks - at Seeking Alpha - Wed Feb 25, 7:05AM CST

VRX: 175.94 (+4.77), SLXP: 172.96 (+0.15), ICPT: 181.90 (-8.81), SPPI: 6.20 (+0.07), EXAS: 8.51 (+0.71)

MDxHealth Named Euronext Best BEL Small Company Performer for 2014
GlobeNewswire - Wed Jan 21, 1:05AM CST
MDxHealth SA (Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that Euronext granted the 2014 Best BEL Small Company Award, for the highest return among its peers, to MDxHealth. The award was presented to Dr. Jan Groen, CEO of MDxHealth, by M. Pieter De Crem, Secretary of State for Foreign Trade, at a ceremony last night at the Palais de la Bourse in Brussels, Belgium.

MDxHealth Licenses Epigenetic Technology to oncgnostics GmbH for Cervical Cancer Test
GlobeNewswire - Wed Jan 14, 1:06AM CST
MDxHealth SA (Euronext: MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that it has granted a limited worldwide license for its patented methylation specific PCR (MSP) technology to oncgnostics GmbH in Jena, Germany.

MDxHealth CEO Dr Jan Groen to Deliver Keynote Presentation at Biomarkers from Research to Clinic Conference
GlobeNewswire - Mon Jan 05, 1:04AM CST
MDxHealth SA (Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, announced today that its CEO, Dr Jan Groen, will deliver a keynote presentation at the Biomarkers from Research to Clinic, Prognostic, Predictive & Point-of-Care Conference at 13:15 PST on January 15 in San Diego, CA, USA.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 96

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 84

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 80

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 103

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 85

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 59

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 59

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Fly Play hf. Amid Takeover Talks

Updated Category News Views 224

Understanding the Recent Developments at Fly Play hf. Fly Play hf. is currently navigating through a significant phase in its operational journey. Amid potential takeover discussions, stakeholders are keenly interested in how such a move could reshape the airline's direction. As the aviation industry continues to evolve, Fly Play's adaptability and innovative strategies...

Continue Reading
AvePoint Aims for Dual Listing at Singapore Exchange

Updated Category News Views 275

AvePoint's Ambitious Step Towards Dual Listing AvePoint (Nasdaq: AVPT), renowned as a leader in data security, governance, and resilience, is taking a significant step forward by submitting an application to list its shares on the Singapore Exchange Securities Trading Limited (SGX-ST). This application is set against the backdrop of its existing presence on the Nasdaq...

Continue Reading
Kris Kehl Joins Planet Home Lending to Enhance Services

Updated Category News Views 140

Kris Kehl Joins Planet Home Lending Team Planet Home Lending, a prominent national mortgage lender, is excited to announce the addition of Kris Kehl as a Senior Mortgage Loan Officer in California. With over 22 years of extensive experience in the mortgage industry, Kehl brings a relationship-first approach that prioritizes accessibility, clear communication, and...

Continue Reading
The S&P 500: Understanding Future Market Return Challenges

Updated Category News Views 647

Understanding Future Returns for the S&P 500 Recently, there’s been a surge of interest regarding predictions for future returns of the S&P 500. With insights from financial giants like J.P. Morgan and Goldman Sachs indicating a significantly lower return forecast for the coming decade, it’s essential to delve deeper into these evaluations. The consistent message has...

Continue Reading
Investors Can Seize Winds of Change with enCore Energy

Updated Category News Views 183

Understanding the Opportunity with enCore Energy Corp. Investors are currently presented with a significant opportunity to engage in the ongoing developments at enCore Energy Corp. (NASDAQ: EU). The global landscape is rapidly changing, especially in the energy sector, and enCore is no exception. A class action has been filed on behalf of shareholders who purchased...

Continue Reading